Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.

Gene editing, AI-driven drug discovery, and multi-omics integration are converging with new FDA regulatory pathways to bring precision therapies to market faster. These advances, supported by a ...

The fifth annual Golf for a Cure took place Monday in West Springfield to raise awareness and support efforts to find a cure ...

A two-week trial has been scheduled for October in the case against Rachel Leonard, the Cortez woman accused of killing her 5 ...

Ticks could be bad this spring and summer in Pennsylvania. This is how you can test the ticks you find for free at ESU.

Initial genetic tests now confirm the hantavirus on the cruise ship is the known Andes variant, and rule out any relevant ...

What are the first steps that chart the path for a cell to become a blood cell, neuron cell, or pigment cell? Scientists have developed increasingly powerful tools to track those changes, but one ...

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...

A new AI framework estimates how cells change over time and infers the gene regulatory networks controlling those changes.

Activating the GPR133 receptor with a small molecule can rebuild bone from within, offering a new direction for osteoporosis ...

Myriad Genetics, Inc. (NASDAQ:MYGN) has been a staple in the 13F portfolio of Glenview Capital since the third quarter of ...

An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.